In colorectal cancer, EphA2 and EphB2, belonging to the tyrosine kinase receptor family, have been identified as novel markers for colorectal CSCs, whose expression is strongly correlated with the expression of CD44 and Lgr5, as well as the stemness of colorectal cancer cells [111, 112]. Here, EPHB2 is linked to colorectal cancer.